NZ510628A - Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal - Google Patents

Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal

Info

Publication number
NZ510628A
NZ510628A NZ510628A NZ51062899A NZ510628A NZ 510628 A NZ510628 A NZ 510628A NZ 510628 A NZ510628 A NZ 510628A NZ 51062899 A NZ51062899 A NZ 51062899A NZ 510628 A NZ510628 A NZ 510628A
Authority
NZ
New Zealand
Prior art keywords
hydrogen
amino
chloro
halogen
acylamino
Prior art date
Application number
NZ510628A
Other languages
English (en)
Inventor
Maria Emanuel Ryan
Lorne M Golub
Nungavaram S Ramamurthy
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of NZ510628A publication Critical patent/NZ510628A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ510628A 1998-09-28 1999-09-28 Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal NZ510628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10205698P 1998-09-28 1998-09-28
PCT/US1999/022354 WO2000018353A2 (fr) 1998-09-28 1999-09-28 Nouvel inhibiteur de formation de cataracte

Publications (1)

Publication Number Publication Date
NZ510628A true NZ510628A (en) 2003-08-29

Family

ID=22287890

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510628A NZ510628A (en) 1998-09-28 1999-09-28 Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal

Country Status (7)

Country Link
EP (1) EP1124558A4 (fr)
JP (1) JP2002525299A (fr)
KR (1) KR20010073190A (fr)
AU (1) AU759372B2 (fr)
CA (1) CA2343038A1 (fr)
NZ (1) NZ510628A (fr)
WO (1) WO2000018353A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69932846T2 (de) * 1998-11-18 2007-03-15 Collagenex Pharmaceuticals, Inc. Neue 4-dedimethylaminotetracyclinderivate
US6506740B1 (en) 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
NZ529308A (en) * 2001-04-05 2005-03-24 Collagenex Pharm Inc Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
EP1383508B1 (fr) * 2001-04-05 2006-06-21 Collagenex Pharmaceuticals, Inc. Doxycycline destinee au traitement de l'acne
JP2005514410A (ja) * 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
PT1615622E (pt) 2003-04-07 2012-10-17 Supernus Pharmaceuticals Inc Formulações de doxiciclinas de dose única diária
CA2732883C (fr) 2008-08-08 2018-03-06 Tetraphase Pharmaceuticals, Inc. Composes de tetracycline c7-fluorosubstituee
WO2010129057A2 (fr) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Composés de tétracycline
WO2011025982A2 (fr) 2009-08-28 2011-03-03 Tetraphase Pharmaceuticals, Inc. Composés tétracycline
SI2890673T1 (sl) 2012-08-31 2019-05-31 Tetraphase Pharmaceuticals, Inc. Spojine tetraciklina
US10961190B2 (en) 2016-10-19 2021-03-30 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS275231B2 (en) * 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle
JPH0515954A (ja) * 1991-07-10 1993-01-26 Harima Ceramic Co Ltd ポーラス質スライデイングノズルプレート
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
JPH09315954A (ja) * 1996-05-30 1997-12-09 Kita:Kk 眼科手術後の眼組織混濁防止剤。
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
US5929055A (en) * 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus

Also Published As

Publication number Publication date
EP1124558A4 (fr) 2004-10-27
AU6268499A (en) 2000-04-17
EP1124558A2 (fr) 2001-08-22
WO2000018353A2 (fr) 2000-04-06
KR20010073190A (ko) 2001-07-31
CA2343038A1 (fr) 2000-04-06
JP2002525299A (ja) 2002-08-13
WO2000018353A3 (fr) 2000-07-06
AU759372B2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
US6914057B1 (en) Inhibitor of cataract formation
AU2002256092B2 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
US5597560A (en) Diclofenac and tobramycin formulations for ophthalmic and otic topicaluse
US20040171591A1 (en) Method for decreasing low density lipoprotein
AU2002256092A1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
AU759372B2 (en) A novel inhibitor of cataract formation
CA2737475A1 (fr) Formulations stabilisant la tetracycline
AU2003226112B2 (en) Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
AU2005222937B2 (en) Method for treating aortic stenosis with non-antibacterial tetracycline formulations
NZ538198A (en) Method for reducing C-reactive protein (CRP) levels by administering a non-antibacterial tetracycline formulation or a low dose of an antibacterial tetracycline formulation
NZ522733A (en) Non-antibacterial tetracycline as anti-fungal agents
WO2004054509A2 (fr) Tetracyclines en tant qu'agents antifongiques pour le traitement de la teigne

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)